SUTENT
- Sunitinib - Carcino- Chemotherapeutic Drugs - (April 2007)
Compositions:
Sunitinib 12.5mg/25mg/50mg capsules,
List of Related Indications:
Sunitinib 12.5mg/25mg/50mg capsules,
- Metastatic renal cell carcinoma (RCC)
Strength | Rate | Packing Style |
---|---|---|
12.5mg | 16071.14 | 7s capsules |
25mg | 61595.90 | 7s capsules |
50mg | 61595.00 | 7s capsules |